Company / Gross Profit per Share
Anika Therapeutics, Inc. Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$4.43
FY2025
5-year range
$4.43 / $5.99
FY2021-FY2025
Trend
-14.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit per Share has fluctuated over the past 10 years, ranging from $0.91 in FY2018 to $5.99 in FY2021.
Based on SEC 10-K filings.
4.43 in FY2025 with a 5-year CAGR of -3.1%.
Declined from $5.64 to $4.43 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -2.5%
- 5-Year CAGR
- -3.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, gross profit per share decreased 14.6% year-over-year.
- Peak gross profit per share was recorded in FY2021.
- Lowest gross profit per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.43 | -14.6% |
| FY2024 | $5.18 | -8.1% |
| FY2023 | $5.64 | +18.1% |
| FY2022 | $4.78 | -20.2% |
| FY2021 | $5.99 | +15.4% |
| FY2020 | $5.19 | +323.8% |
| FY2019 | $1.22 | +34.1% |
| FY2018 | $0.91 | -22.8% |
| FY2017 | $1.18 | +5.5% |
| FY2016 | $1.12 | +48.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026